Sunday March 21 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Oxyurida Infections

Below is an extended Oxyurida Infections news listing. Click here to return to the Oxyurida Infections main in depth entry.

BioNews Results for Oxyurida Infections:

Dialysis Procedures Tightened in Wake of Hepatitis Infections
China Development Gateway:  Mar 13 2010 4:49AM Matching: infections
Idera Pharmaceuticals to Present an Overview of Toll-like Receptor Antagonist Program at 8th World Congress on
Pharmacy Choice:  Mar 12 2010 10:31PM Matching: infections
Idera Pharmaceuticals to Present an Overview of Toll-like Receptor Antagonist Program at 8th World Congress on
Pharma Live:  Mar 12 2010 7:56PM Matching: infections
Idera Pharmaceuticals to Present an Overview of Toll-like Receptor Antagonist Program at 8th World Congress on
Therapeutics Daily:  Mar 12 2010 7:54PM Matching: infections
Idera Pharmaceuticals to Present an Overview of Toll-like Receptor Antagonist Program at 8th World Congress on Trauma, Shock, Inflammation and Sepsis
Yahoo! Canada:  Mar 12 2010 6:43PM Matching: infections
Can H. pylori Infections Be Eradicated?
Infection Control Today:  Mar 12 2010 5:36PM Matching: infections
Idera Pharmaceuticals to Present an Overview of Toll-like Receptor Antagonist Program at 8th World Congress on Trauma, Shock, Inflammation and Sepsis
SmartBrief:  Mar 12 2010 3:51PM Matching: infections
Idera Pharmaceuticals to Present an Overview of Toll-like Receptor Antagonist Program at 8th World Congress on Trauma, Shock, Inflammation and Sepsis
FOXBusiness.com:  Mar 12 2010 2:25PM Matching: infections
Idera Pharmaceuticals to Present an Overview of Toll-like Receptor Antagonist Program at 8th World Congress on Trauma, Shock, Inflammation and Sepsis
FOXBusiness.com:  Mar 12 2010 2:24PM Matching: infections
Idera Pharmaceuticals to Present an Overview of Toll-like Receptor Antagonist Program at 8th World Congress on Trauma, Shock, Inflammation and Sepsis
Centre Daily Times:  Mar 12 2010 2:22PM Matching: infections
BioMerieux Launches Industry-First Vancomycin-Resistant Enterococci (VRE) Screening Tool
Medical News Today:  Mar 12 2010 2:07PM Matching: infections
Idera Pharmaceuticals to Present an Overview of Toll-like Receptor Antagonist Program at 8th
Forbes.com:  Mar 12 2010 1:55PM Matching: infections
Idera Pharmaceuticals to Present an Overview of Toll-like Receptor Antagonist Program at 8th World Congress on
EON:  Mar 12 2010 1:44PM Matching: infections
Idera Pharmaceuticals to Present an Overview of Toll-like Receptor Antagonist Program at 8th World Congress on Trauma, S
NewsBlaze:  Mar 12 2010 1:44PM Matching: infections
Idera Pharmaceuticals to Present an Overview of Toll-like Receptor Antagonist Program at 8th World Congress on Trauma, Shock, Inflammation and Sepsis
Street Insider:  Mar 12 2010 1:43PM Matching: infections

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2010 - BioPortfolio Limited.